Tianxin Lin Selected Research

Tianxin Lin Research Topics

Disease

52	Urinary Bladder Neoplasms (Bladder Cancer) 07/2022 - 05/2008
44	Neoplasms (Cancer) 06/2022 - 12/2003
24	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2008
14	Prostatic Neoplasms (Prostate Cancer) 07/2021 - 09/2011
12	Lymphatic Metastasis 01/2022 - 10/2013
9	Carcinoma (Carcinomatosis) 03/2022 - 11/2010
6	Carcinogenesis 10/2018 - 04/2011
4	Non-Muscle Invasive Bladder Neoplasms 06/2022 - 09/2010
2	Renal Cell Carcinoma (Grawitz Tumor) 04/2016 - 04/2013
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2013 - 10/2009
1	Infections 06/2022
1	Leukemia 01/2022
1	Ischemia 01/2020
1	Hypoxia (Hypoxemia) 01/2019
1	Pathologic Processes 10/2018
1	Flatulence 01/2018
1	Adenocarcinoma 05/2017
1	Liver Neoplasms (Liver Cancer) 05/2017
1	Inflammation (Inflammations) 05/2017
1	Ovarian Neoplasms (Ovarian Cancer) 05/2017
1	Pelvic Pain 09/2016
1	Hydronephrosis 09/2016

Drug/Important Bio-Agent (IBA)

16	Circular RNAIBA 01/2022 - 10/2018
12	Long Noncoding RNAIBA 01/2021 - 10/2013
12	Biological ProductsIBA 03/2020 - 04/2011
11	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2015
8	MicroRNAs (MicroRNA)IBA 03/2020 - 03/2009
6	Proteins (Proteins, Gene)FDA Link 10/2018 - 04/2011
5	AntigensIBA 07/2021 - 09/2011
5	Cisplatin (Platino)FDA LinkGeneric 06/2021 - 02/2014
5	Small Interfering RNA (siRNA)IBA 01/2019 - 09/2011
4	Vascular Endothelial Growth Factor CIBA 01/2021 - 01/2018
4	Messenger RNA (mRNA)IBA 01/2021 - 04/2011
3	LigandsIBA 01/2022 - 08/2015
3	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2019
3	AndrogensIBA 01/2019 - 01/2017
2	Lysine (L-Lysine)FDA Link 01/2022 - 02/2015
2	histone H3 trimethyl Lys4IBA 01/2022 - 06/2021
2	Histones (Histone)IBA 01/2022 - 02/2015
2	B7-H1 AntigenIBA 06/2021 - 01/2021
2	Polypyrimidine Tract-Binding ProteinIBA 03/2021 - 01/2019
2	UbiquitinIBA 01/2021 - 05/2017
2	RNA Splicing FactorsIBA 01/2021 - 01/2019
2	cyclobutanecarbonylcarnitine (CBCC)IBA 07/2020 - 04/2015
2	AcidsIBA 01/2020 - 04/2011
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2017 - 01/2014
2	plastinIBA 10/2017 - 01/2016
2	Cyclin B1IBA 06/2015 - 02/2015
2	pirarubicinIBA 05/2015 - 11/2010
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2013 - 05/2012
2	CaspasesIBA 01/2013 - 05/2012
2	13-methyltetradecanoic acidIBA 01/2013 - 05/2012
1	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 07/2022
1	VaccinesIBA 06/2022
1	Hemagglutinins (Hemagglutinin)IBA 06/2022
1	Mannose (D-Mannose)IBA 06/2022
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2022
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022
1	N2- (1H- indazole- 5- yl)- N6- methyl- 3- nitropyridine- 2,6- diamineIBA 01/2022
1	Immunoconjugates (Immunoconjugate)IBA 01/2022
1	PlatinumIBA 01/2022
1	ChemokinesIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Lymphoid Enhancer-Binding Factor 1IBA 01/2022
1	E2F Transcription FactorsIBA 01/2022
1	Metalloproteases (Metalloproteinases)IBA 01/2022
1	OICR-9429IBA 06/2021
1	Aurora Kinase AIBA 06/2021
1	SAR131675IBA 01/2021
1	Proline (L-Proline)FDA Link 01/2021
1	Glutamine (L-Glutamine)FDA Link 01/2021
1	Carrier Proteins (Binding Protein)IBA 01/2021
1	RNA Precursors (Precursor, mRNA)IBA 01/2021
1	Factor X (Stuart Factor)IBA 03/2020
1	5-aminolevulinic acid hexyl ester FDA Link 01/2020
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 12/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2019
1	Untranslated RNA (Noncoding RNA)IBA 01/2019
1	Androgen Receptors (Androgen Receptor)IBA 01/2019
1	Docetaxel (Taxotere)FDA Link 01/2018
1	Hormones (Hormone)IBA 10/2017
1	sharpinIBA 05/2017
1	NF-kappa B (NF-kB)IBA 05/2017
1	Cyclin D1IBA 01/2017
1	Heterogeneous-Nuclear Ribonucleoprotein KIBA 01/2017
1	EndonucleasesIBA 01/2017

Therapy/Procedure

11	Therapeutics 06/2022 - 04/2011
8	Cystectomy 07/2020 - 12/2003
7	Immunotherapy 06/2022 - 01/2020
7	Drug Therapy (Chemotherapy) 01/2022 - 10/2009
5	Nephrectomy 01/2020 - 10/2012
4	Castration 01/2019 - 01/2017
4	Length of Stay 01/2018 - 10/2012
2	Aftercare (After-Treatment) 06/2022 - 09/2016
2	Nephroureterectomy 09/2021 - 01/2021
2	Warm Ischemia 01/2020 - 01/2013
2	Operative Time 06/2014 - 10/2012
2	Lymph Node Excision (Lymph Node Dissection) 05/2014 - 09/2010
1	Urinary Diversion (Ileal Conduit) 01/2018
1	Enhanced Recovery After Surgery 01/2018